These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25488381)

  • 41. Biventricular pacing for atrioventricular block and systolic dysfunction.
    Curtis AB; Worley SJ; Adamson PB; Chung ES; Niazi I; Sherfesee L; Shinn T; Sutton MS;
    N Engl J Med; 2013 Apr; 368(17):1585-93. PubMed ID: 23614585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation.
    Orlov MV; Gardin JM; Slawsky M; Bess RL; Cohen G; Bailey W; Plumb V; Flathmann H; de Metz K
    Am Heart J; 2010 Feb; 159(2):264-70. PubMed ID: 20152225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimisation of cardiac resynchronisation therapy device selection guided by cardiac magnetic resonance imaging: Cost-effectiveness analysis.
    Crespo C; Linhart M; Acosta J; Soto-Iglesias D; Martínez M; Jáuregui B; Mira Á; Restovic G; Sagarra J; Auricchio A; Fahn B; Boltyenkov A; Lasalvia L; Sampietro-Colom L; Berruezo A
    Eur J Prev Cardiol; 2020 Apr; 27(6):622-632. PubMed ID: 31487998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy.
    Arbelo E; Tolosana JM; Trucco E; Penela D; Borràs R; Doltra A; Andreu D; Aceña M; Berruezo A; Sitges M; Mansour F; Castel A; Matas M; Brugada J; Mont L
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):283-92. PubMed ID: 24237881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should all patients with heart block receive biventricular pacing? All heart block patients with a pacemaker indication should receive biventricular pacing: one move, double the gains?
    Fang F; Sanderson JE; Yu CM
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):722-9. PubMed ID: 26082528
    [No Abstract]   [Full Text] [Related]  

  • 46. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF).
    Stockburger M; Gómez-Doblas JJ; Lamas G; Alzueta J; Fernández-Lozano I; Cobo E; Wiegand U; Concha JF; Navarro X; Navarro-López F; de Teresa E
    Eur J Heart Fail; 2011 Jun; 13(6):633-41. PubMed ID: 21613427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac resynchronization therapy in patients with atrial fibrillation: a meta-analysis.
    Lopes C; Pereira T; Barra S
    Rev Port Cardiol; 2014 Nov; 33(11):717-25. PubMed ID: 25457476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiarrhythmic effect of cardiac resynchronization therapy with triple-site biventricular stimulation.
    Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Mizuno K
    Europace; 2013 Oct; 15(10):1491-8. PubMed ID: 23696627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
    Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of different ventricular pacing modes on ventricular repolarisation in patients undergoing cardiac resynchronisation therapy: a single-centre study.
    Min G; Shaoxin Z; Chang F; Juan L; Guiyi Y; Shuxian Z
    Heart Lung Circ; 2014 Jul; 23(7):644-8. PubMed ID: 24713298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Usefulness of incremental atrial pacing for evaluating the effectiveness of the ablation of the slow perinodal pathway].
    Martínez-Sánchez J; García-Alberola A; Sánchez-Muñoz JJ; Cerdán-Sánchez C; Redondo-Bermejo B; Ruipérez-Abizanda JA; Valdés-Chávarri M
    Rev Esp Cardiol; 2007 Jan; 60(1):32-7. PubMed ID: 17288953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left ventricular function during and after right ventricular pacing.
    Nahlawi M; Waligora M; Spies SM; Bonow RO; Kadish AH; Goldberger JJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1883-8. PubMed ID: 15519023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term clinical response to cardiac resynchronisation therapy under a multidisciplinary model.
    O'Donnell D; Lin T; Swale M; Rae P; Flannery D; Srivastava PM
    Intern Med J; 2013 Nov; 43(11):1216-23. PubMed ID: 24015775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular nodal block.
    Hay I; Melenovsky V; Fetics BJ; Judge DP; Kramer A; Spinelli J; Reister C; Kass DA; Berger RD
    Circulation; 2004 Nov; 110(22):3404-10. PubMed ID: 15557370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rate or Rhythm Control in CRT (RHYTHMIC): Study rationale and protocol.
    Elliott MK; de Vere F; Mehta VS; Wijesuriya N; Strocchi M; Rajani R; Niederer S; Rinaldi CA
    Heart Rhythm O2; 2022 Dec; 3(6Part A):681-687. PubMed ID: 36589918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.